GERON CORP — Director's Dealing 2010

Jul 13, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GERON CORP (GERN)
CIK: 0000886744
Period of Report: 2010-07-09

Reporting Person: BEHRS MELISSA KELLY (SVP Oncology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-07-09	Common Stock	A	105000	—	Acquired	241048	Direct
2010-07-09	Common Stock	A	15000	—	Acquired	256048	Direct
2010-07-09	Common Stock	A	15000	—	Acquired	271048	Direct
2010-07-09	Common Stock	A	90000	—	Acquired	361048	Direct

Footnotes

F1: The shares of restricted stock will remain subject to a reacquisition right of Geron over three years until the achievement of certain performance milestone criteria in connection with the Company's imetelstat program.

F2: The shares of restricted stock will remain subject to a reacquisition right of Geron over three years until the achievement of certain performance milestone criteria in connection with the Company's GRNOPC1 program.

F3: The shares of restricted stock will remain subject to a reacquisition right of Geron over three years until the achievement of certain performance milestone criteria in connection with the Company's strategic initiatives.

F4: The shares of restricted stock will remain subject to a reacquisition right of Geron over three years until the Company's common stock price exceeds certain thresholds.